Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127150601 | 12715060 | 1 | I | 20160823 | 20160905 | 20160905 | EXP | US-ALLERGAN-1667533US | ALLERGAN | BAZARI H, PALMER WE, BARON JM, ARMSTRONG K.. CASE 24-2016: A 66-YEAR-OLD MAN WITH MALAISE, WEAKNESS, AND HYPERCALCEMIA. NEW ENGLAND JOURNAL OF MEDICINE. 2016;375(6):567-574 | 66.00 | YR | M | Y | 0.00000 | 20160905 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127150601 | 12715060 | 1 | PS | HYDROCHLOROTHIAZIDE Unk | HYDROCHLOROTHIAZIDE | 1 | Y | 20504 | |||||||||||
127150601 | 12715060 | 2 | SS | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Y | 0 | |||||||||||
127150601 | 12715060 | 3 | SS | NAPROXEN. | NAPROXEN | 1 | UNK | U | 0 | ||||||||||
127150601 | 12715060 | 4 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 5 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 6 | SS | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 8 | C | TAMSULOSIN | TAMSULOSIN | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 9 | C | FATTY ACIDS NOS | 2 | U | 0 | ||||||||||||
127150601 | 12715060 | 10 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 11 | C | TADALAFIL | TADALAFIL | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 12 | C | DISULFIRAM. | DISULFIRAM | 1 | UNK, PRN | U | 0 | ||||||||||
127150601 | 12715060 | 13 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | U | 0 | |||||||||||
127150601 | 12715060 | 14 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127150601 | 12715060 | 1 | Hypertension |
127150601 | 12715060 | 2 | Dyspepsia |
127150601 | 12715060 | 3 | Musculoskeletal disorder |
127150601 | 12715060 | 5 | Musculoskeletal discomfort |
127150601 | 12715060 | 6 | Musculoskeletal disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127150601 | 12715060 | HO |
127150601 | 12715060 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127150601 | 12715060 | Acute kidney injury | |
127150601 | 12715060 | Hypercalcaemia | |
127150601 | 12715060 | Metabolic alkalosis | |
127150601 | 12715060 | Milk-alkali syndrome | |
127150601 | 12715060 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |